Skip to main content
Journal ArticleOPEN ACCESS

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

  • Havervall S
  • Marking U
  • Svensson J
  • et al.
New England Journal of Medicine (2022) 387(14) 1333-1336
DOI: 10.1056/nejmc2209651
145Citations
Citations of this article
88Readers
Mendeley users who have this article in their library.

Abstract

BNT162b2 Protection against Hospitalization in South Africa After either two doses or three doses of the BNT162b2 vaccine, effectiveness against the current sublineages of the omicron variant in So...

Cite

CITATION STYLE

APA

Havervall, S., Marking, U., Svensson, J., Greilert-Norin, N., Bacchus, P., Nilsson, P., … Thålin, C. (2022). Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection. New England Journal of Medicine, 387(14), 1333–1336. https://doi.org/10.1056/nejmc2209651

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free